Today’s AI Top Pick: PODD

7/16/2026 · Reliable Bullish screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · PODD80%181 resolved forecasts · 45d window · verify →

Today's pick · Reliable BullishPODDBUY NOW9.1 / 107/16/2026

Insulet (PODD) is the cleanest multi-timeframe bullish setup in the pool with the fundamentals to back it up. The forecast tape lines up on 4h/1d/1wk — 1d fc_mid +50.65% and fc_long +62.44%, 1wk fc_mid +33.8% and fc_long +52.31%, plus 4h fc_long +52.72%. Bullish probability is 1.0 with near_term_bullish 1.0, and the 1h dip (-8.88% short) is a minor, expected pullback into a stock that is deeply drawn down (-35.12% from 21-bar highs on the weekly, -43.96% YTD). The weekly range position is only 14.81% — you are NOT chasing an extended tape; you are buying an oversold quality name that just turned. Fundamentally this is one of the strongest names on the sheet: 31.93% sales growth, 23% ROE, 10.44% profit margin, gross margin 71.64%, forward P/E 19.78 on epsNextY of 24.34%, PEG 0.74, analyst recom 1.44, and 47.5% consensus target upside. That combination — high growth + high ROE + reasonable forward multiple + deep drawdown — is exactly what the reliable_bullish lens is designed to surface. Fundamental_score is 8, the top of the range. The newsflow confirms rather than undercuts: July 16 ChartMill flagged PODD as "A Quality Affordable Growth Stock With Strong Earnings Momentum," and the broader CGM market is projected to grow 8.9% CAGR to $39.4B by 2035. No guidance cuts, no legal/regulatory overhangs, no dilution headlines. Contrast with PEGA (recent SA downgrade — "Shakier Future Ahead"), CRK (missed Q1, on a cash-burn list), and EQX (1wk fc -38% is a landmine). Why today and not wait: the 1d closed at 82.44% of range with dd only -2.72%, momentum has already turned (1d +8.34%, 4h +4.09%), and yet the WEEKLY chart still shows massive room to mean-revert. That combination — daily breakout underway, weekly still deeply oversold — is the classic asymmetric entry. Waiting risks chasing after another leg up given how strong the forecast magnitudes are.

Entry zone

$156-$161 (buy starter at market ~$160, add on any dip toward $156-$157 which was the recent 4h consolidation)

Stop loss

$148 (below the 1d dd_from_high pivot and the -8% 4h drawdown line; risk ~7-8% from entry)

First target

$178-$182 (aligns with 1d fc_short +10.45% and 4h fc_mid +19.37%, roughly a 21-bar range reclaim)

Longer target

$220-$245 (1d fc_mid/long +50-62% and 1wk fc_long +52% zone; also matches ~47% consensus target upside)

Risks

Stock is down 43.96% YTD and 45.07% YoY — a broken chart on the weekly means overhead supply at $190-$210 could stall the rally
1h fc_short -8.88% suggests near-term choppiness; a bad tape day could hit the stop before the daily thesis plays out
Short float 7.04% is elevated for a medtech; any earnings miss or CGM competitive news (Dexcom/Abbott) could accelerate downside
Forward P/E of 19.78 is reasonable but not cheap — if growth decelerates below the 31.9% salesYoY pace, multiple compresses fast
Institutional ownership at 104.9% signals crowded positioning; a rotation out of medtech growth would hurt disproportionately

Honorable mentions

EXLSFresh analyst upgrade to Buy (Jul 13), all four TFs bullish (1d fc_mid +36.93%, 1wk fc_long +20.19%), not extended (1wk pos_in_range 27%, dd -14.76%), fundamental_score 8, PEG 0.68, roe 28. Cleanest 'no-drama' setup after PODD.

TRMBMulti-TF alignment with near_term_bullish 1.0, 1d fc_mid +40.7% and 1wk fc_long +28.99%, 1wk pos_in_range only 13.19% with -25.91% drawdown. Analyst PT cuts are a minor drag but recom 1.44 and 58.4% target upside offset it.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	PODD	BUY NOW	9.1	All-TF bullish, huge forecast magnitude (1d +50%, 1wk +52%), deep weekly drawdown gives room to run — no news landmines.
2	EXLS	BUY NOW	8.4	Fresh analyst upgrade + fundamental_score 8; 1d fc_mid +36.93%, all TFs green, mid-range positioning means no chase.
3	TRMB	BUY NOW	8.1	Strong multi-TF (1d fc_mid +40.7%, 1wk fc_long +28.99%), 1wk range pos 13%, near_term 1.0 — deep oversold breakout.
4	MORN	BUY NOW	7.9	near_term 1.0, 1wk fc_long +47.26%, roe 30.66, only -22% YTD drawdown — high-quality slow-turn setup.
5	PTC	BUY NOW	7.7	Positive ALM/Codebeamer catalyst, 1d fc_long +37.22%, 4h fc_long +21%, fundamental_score 8, salesYoY 27.75%.
6	ADSK	BUY PULLBACK	7.5	All TFs bullish and near_term 1.0, but 1h/1d pos_in_range 96-97% — wait for a pullback to $205.
7	MNSO	BUY PULLBACK	7.3	1d fc_mid +47.89%, PEG 0.17, recom 1.22 — but at 100% of daily range, chase risk high.
8	PDD	BUY PULLBACK	7.2	Cheapest of the pack (fwdPe 6.95, PEG 0.62), 1d fc +17%, but 1d pos 100% and 1h fc negative — wait for dip.
9	PEGA	BUY PULLBACK	6.7	Strongest weekly setup (pos 8.07%, dd -33%), but SA downgrade on Jul 8 caps conviction; near_term only 0.2.
10	FIGR	BUY PULLBACK	6.6	Piper/KBW maintain Outperform; missing 1wk TF and bullish_prob null keep this from being top-tier confidence.
11	CRM	BUY PULLBACK	6.5	1d fc_mid +23.16%, 1wk fc_long +32.3%, fwdPe 10.69 — but 1h fc negative and AI sentiment mixed.
12	BILI	BUY PULLBACK	6.3	1d fc_mid +39%, buyback catalyst, but 1wk fc_long -4.42% is a red flag and 1d at 100% of range.
13	LOPE	BUY PULLBACK	6.2	Recom 1.00, all TFs bullish, but 1wk fc_long only +0.65% and PT cut by BMO — modest edge.
14	FINV	BUY PULLBACK	6.1	fwdPe 3.3, PEG 0.7, 1d fc_mid +26.61% — micro-cap ($612M) liquidity risk holds it back.
15	HURN	BUY PULLBACK	5.9	1d at 100% of range and 1h fc_short -10.32% signals near-term exhaustion; weekly forecast also negative.
16	CALX	WAIT	5.7	Earnings next week + pe 81 + operMargin 3.75% — too event-risky right now despite 1d fc +8.41%.
17	ADBE	BUY PULLBACK	5.6	1wk fc numbers (+48/77/96%) look outlier-huge; recom 2.59 lukewarm; wait for AI sentiment to stabilize.
18	TMUS	WAIT	5.4	1wk fc_mid/long negative (-4.17/-6.94%), 1h negative — signal deteriorating despite solid fundamentals.
19	CMCSA	WAIT	5.3	1d fc_mid +18.37% is nice, but recom 2.52 and secular cord-cut concerns keep conviction low.
20	EFX	WAIT	5.2	Earnings next week, 1h fc negative, wait for print before entering.
21	GIB	WAIT	5.0	All TFs green but forecast magnitude modest (1wk fc_long +36% is best); no strong catalyst today.
22	TYL	WAIT	4.9	Earnings preview scheduled; fundamental_score 5.75 and pe 41.93 make it a lower-priority buy.
23	UHS	WAIT	4.7	Shares trading lower on Jul 14, recom 2.48, and 4h/1d positioning weak — wait for stabilization.
24	CELH	WAIT	4.6	1wk fc_short -7.7% and 1wk pos 8.24% — deep hole; needs proof of turn before entering.
25	EXE	WAIT	4.5	epsNextY -4.74% and 1wk fc_mid -7.37% contradict the earnings-beat narrative; nat gas sensitivity.
26	HUBS	WAIT	4.3	PE 112.92, operMargin 2.02%, and Simply Wall St flag on slower demand — expensive with deteriorating story.
27	CCLD	WAIT	4.1	$100M micro-cap; screen score OK but no meaningful institutional/analyst support and no catalyst.
28	CRK	AVOID	3.8	1wk fc_long -16.07%, on a 'cash-burning stocks' list, missed Q1 — screen pass but broken tape.
29	AUGO	AVOID	3.6	Insider selling, SA piece warning market too optimistic on gold, 1wk data missing — too many yellow flags.
30	EQX	AVOID	3.2	1wk fc_long -38.33% and 1wk dd -50.45% — the weekly forecast contradicts the bullish screen; broken setup.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord